Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

redpharm drug inc. - dicloxacillin sodium (unii: 4hzt2v9kx0) (dicloxacillin - unii:cof19h7wbk) - dicloxacillin 500 mg - to reduce the development of drug-resistant bacteria and maintain the effectiveness of dicloxacillin sodium capsules usp and other antibacterial drugs, dicloxacillin sodium capsules usp should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. dicloxacillin is indicated in the treatment of infections caused by penicillinase-producing staphylococci which have demonstrated susceptibility to the drug. cultures and susceptibility tests should be performed initially to determine the causative organisms and their sensitivity to the drug. (see clinical pharmacology – susceptibility plate testing ). dicloxacillin may be used to initiate therapy in suspected cases of resistant staphylococcal i

Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

pd-rx pharmaceuticals, inc. - dicloxacillin sodium (unii: 4hzt2v9kx0) (dicloxacillin - unii:cof19h7wbk) - dicloxacillin 250 mg - to reduce the development of drug-resistant bacteria and maintain the effectiveness of dicloxacillin sodium capsules and other antibacterial drugs, dicloxacillin sodium capsules should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. dicloxacillin is indicated in the treatment of infections caused by penicillinase-producing staphylococci which have demonstrated susceptibility to the drug. cultures and susceptibility tests should be performed initially to determine the causative organisms and their sensitivity to the drug (see clinical pharmacology – susceptibility  testing ) . dicloxacillin may be used to initiate therapy in suspected cases of resistant stap

Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

liberty pharmaceuticals, inc. - dicloxacillin sodium (unii: 4hzt2v9kx0) (dicloxacillin - unii:cof19h7wbk) - dicloxacillin 250 mg - to reduce the development of drug-resistant bacteria and maintain the effectiveness of dicloxacillin sodium capsules usp and other antibacterial drugs, dicloxacillin sodium capsules usp should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. dicloxacillin is indicated in the treatment of infections caused by penicillinase-producing staphylococci which have demonstrated susceptibility to the drug. cultures and susceptibility tests should be performed initially to determine the causative organisms and their sensitivity to the drug. (see clinical pharmacology – susceptibility plate testing ). dicloxacillin may be used to initiate therapy in suspected cases of resistant staphylococcal i

Australia - Inggeris - APVMA (Australian Pesticides and Veterinary Medicines Authority)

intervet australia pty limited - cloxacillin as the benzathine salt; brilliant blue fcf - misc. intra mammary - cloxacillin as the benzathine salt antibiotic active 600.0 mg/3.6gs; brilliant blue fcf dye-blue other 25.0 mg/3.6gs - antibiotic & related - dairy cattle | bovine | breeders | calves | dairy cow | growers | lactating cow | milking cow - corynebacterium spp. | mastitis | staphylococcus spp. | streptococcus spp. | bacterial canker | staphylococcosis | subclinical mastitis

Australia - Inggeris - APVMA (Australian Pesticides and Veterinary Medicines Authority)

zoetis australia pty ltd - cloxacillin as the benzathine salt - misc. intra mammary - cloxacillin as the benzathine salt antibiotic active 600.0 mg/3.6gd - antibiotic & related - dairy cattle | bovine | breeders | calves | dairy cow | growers | lactating cow | milking cow - mastitis | subclinical mastitis

Australia - Inggeris - APVMA (Australian Pesticides and Veterinary Medicines Authority)

norbrook laboratories australia pty limited - cloxacillin as the benzathine salt - misc. aural, ophthalmic, oro/naso pharyngeal - cloxacillin as the benzathine salt antibiotic active 833.0 mg/sg - ophthalmic preparations - cat | cattle | dog | horse | sheep | beef | bitch | bos indicus | bos taurus | bovine | buffalo | bull | bullock | calf | castra - bacterial kerato conjunctivitis

Australia - Inggeris - APVMA (Australian Pesticides and Veterinary Medicines Authority)

avet health limited - cloxacillin as the benzathine salt - misc. intra mammary - cloxacillin as the benzathine salt antibiotic active 166.7 mg/g - antibiotic & related - cow | bovine | female cattle - mastitis | subclinical mastitis

Australia - Inggeris - APVMA (Australian Pesticides and Veterinary Medicines Authority)

norbrook laboratories australia pty limited - cloxacillin as the benzathine salt - misc. intra mammary - cloxacillin as the benzathine salt antibiotic active 500.0 mg/4.5g - antibiotic & related - dairy cattle | bovine | breeders | calves | dairy cow | growers | lactating cow | milking cow - mastitis | subclinical mastitis

Australia - Inggeris - APVMA (Australian Pesticides and Veterinary Medicines Authority)

avet health limited - ampicillin trihydrate; cloxacillin as the benzathine salt - misc. intra mammary - ampicillin trihydrate antibiotic active 250.0 mg/sg; cloxacillin as the benzathine salt antibiotic active 500.0 mg/sg - antibiotic & related - cow-not lactating-preg. not w/i 1mth cal | dairy cattle dry | dairy cattle lactating | bovine | cow | cow pregnant not within 1 - antibiotic - anti-infective | abrasions | abscesses | airsacculitis | antiseptic | avian mycoplasmas | blackhead | body odours | bowed tendons | broad spectrum | burns | coccidiosis | coliform complex | conjunctivitis | cowpox | cracks | crusts | dandruff | dermatological disorders | dermatosis | dry skin | dysentery | eczema | endometritis | enteric diseases | enzootic pneumonia | feed efficiency | fungal infections | girth galls | infections | inflammed pads | itching | keratolytic | lacerations | mastitis | mycoplasmas | odours | open wounds | otitis | pruritis | queensland itch | respiratory disease | saddle rash | salmonellosis | scabs | scaly skin | sheath rot | skin irritations | sores | swine dysentery | teat cracking | teat infections | topical infections | udder sores | weight gain | wire cuts | wounds

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - dicloxacillin sodium, quantity: 542.4 mg (equivalent: dicloxacillin, qty 500 mg) - capsule, hard - excipient ingredients: titanium dioxide; purified water; magnesium stearate; gelatin; colloidal anhydrous silica; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - treatment of confirmed or suspected staphylococcal and other gram positive coccal infections, including skin and skin structure and wound infections, infected burns, cellulitis, osteomyelitis and pneumonia (note: benzylpenicillin is the drug of choice for the treatment of streptococcal pneumonia).,bacteriological studies should be performed to determine the causative organisms and their susceptibility to dicloxacillin. dicloxacillin has less intrinsic antibacterial activity and a narrower spectrum than benzylpenicillin. dicloxacillin should therefore not be used in infections due to organisms susceptible to benzylpenicillin.,important note: when it is judged necessary that treatment is initiated before definitive culture and sensitivity results are known, if the microbiology report later indicates that the infection is due to an organism other than a benzylpenicillin resistant staphylococcus sensitive to dicloxacillin, the physician is advised to continue therapy with a drug other than dicloxacillin or any other penicillinase-resistant penicillin